The Steering Committee
Dennis C. Turk, PhD









You need to upgrade your Flash Player

Member Login
Username:

Password:
Need to register?
Forgot Password?



The Gout Academy
Calendar of Events
Poll
How familiar are you with current developments in the area of opioid Risk Evaluation and Mitigation Strategies (REMS) being proposed by the FDA?




You need to upgrade your Flash Player to view this content.

What's New?

FDA Public Health Advisory: Potential safety risk with opioid medications
Opioid products manufactured and packaged for Endo Pharmaceuticals by Novartis Consumer Health: tablets from one product type may have carried over into packaging of another product. List of products that may be affected, more info available here
Redesigned Opioid Analgesia Tool Kit
The Opioid Analgesia Tool Kit has been thoroughly revised and updated! This user-friendly resource features assessment and documentation tools, patient education materials, and more that will aid you in treating and managing patients receiving chronic opioid therapy.
Persistent Pain in the Older Adult Webcast
This interactive, on-demand webcast from the American Pain Foundation and the NIPC® explores management and treatment of persistent pain in older adults, and features the “Pearls to Practice” worksheet, which allows you to take notes and capture key messages in “real time” as you are viewing the webcast!
Safety Alert: Voluntary Recall of Pain Medications
Endocet® (oxycodone/acetaminophen) has been voluntarily recalled as some bottles may contain different strength tablets. More info. Several lots of Butalbital, Acetaminophen, and Caffeine Tablets, and Hydrocodone Bitartrate and Acetaminophen Tablets, have been voluntarily recalled; recalled bottles may contain incorrect tablets. More info
REMS: What You Need to Know
New in the Slide Library: Key aspects of the proposed FDA class opioid REMS, and opioid safe storage and disposal.
Chronic Opioid Therapy Physician and Patient Resources
Visit our Physician Tools page to view and download three new resources: a worksheet delineating key components to include in each interaction with patients receiving opioid therapy, and two companion patient handouts focusing on preparing for medical appointments and dos and don'ts for using opioids safely and responsibly.
FDA Sets Limit on Acetaminophen Dosages
The FDA has asked drug manufacturers to limit the strength of acetaminophen in prescription drug products to no more than 325 mg. A boxed warning highlighting the potential for severe liver toxicity is also being added to all products containing acetaminophen. More information is available here.

Slides of the Month
 

  slide Fibromyalgia: Overview
This slide was created under the auspices of Clinical Bridges™ and was not associated with fun...
View all Slides

  slide Comparison of Fibromyalgia and Neuropathic Pain: Design
This slide was created under the auspices of Clinical Bridges™ and was not associated with fun...
View all Slides

  slide Comparison of Fibromyalgia and Neuropathic Pain: Results
This slide was created under the auspices of Clinical Bridges™ and was not associated with fun...
View all Slides

In the News
Novartis' Troubles With Packaging Continue
Jan 09, 2012 -- Novartis Consumer Health announced earlier today a recall on certain OTC medicines that were badly packaged and might have broken or chipped pills, as well as incorrect product mixed into bottles of pills. Rather worrying for consumers with risks of possible wrong or overdoses of their medicine...
"Couch Potato Drug" May Protect Against Heat Stroke
Jan 09, 2012 -- An experimental drug that once made the headlines as the "couch potato pill", for its capacity to mimic the effects of exercise in sedentary mice, may have another use, as a way to protect against heat stroke...
Copyright 2012 Medical News Today
This is a free demo result from the Wayback Machine Downloader. Click here to download the full version.